Description:

Title: Advancing psychiatric care through research in clinical neuroscience:

This presentation will review the ways in which research in neuroscience inform therapeutic discovery focusing on the area of anxiety disorders.  A developmental focus will be emphasized, highlighting perturbations in brain function that manifest similarly across ages as well as those that differ in pediatric and adult anxiety disorders.  The presentation also provide relatively broad review of multiple topics relevant to therapeutics as well as a more in-depth consideration of novel treatments arising through research on attention and the insights this reveals for computer-based attention retraining therapies.  

Biography

Dr. Daniel Pine is Chief, Emotion and Development Branch in the National Institute of Mental Health Intramural Research Program.  Dr. Pine moved to this position in 2000, after 10 years of training, teaching, and research at Columbia University.  Since graduating from medical school at the University of Chicago (GO BEARS & CUBS!), Dr. Pine has been engaged continuously in research on pediatric mental disorders, as reflected in more than 700 peer-reviewed papers.  Currently, his group examines the degree to which pediatric mood and anxiety disorders are associated with perturbed neural circuitry function.   Dr. Pine served as the Chair of the Psychopharmacologic Drug Advisory Committee for the Food and Drug Administration, Chair of the Child and Adolescent Disorders Work Group for the DSM-5 Task Force, and President of the Society of Biological Psychiatry.  He is a member of the National Academy of Medicine, a Distinguished Investigator indicating stature as among the 1-2% most impactful National Institute of Health intramural scientists, and he has received many other awards.